RxDoctor Payments Data

John Stanback, MD

Family Medicine · Columbus, MSNPI 1629034764

Payments from drug & device makers

$4,790in general payments, 2019–2025

Across 326 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$931
  • Sanofi-aventis U.S. LLC$735
  • AstraZeneca$619
  • AbbVie$329
  • Bayer$294
  • Johnson & Johnson$279
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,776100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,790 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$159,150
Medicare patients
507
Services billed
4,603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$65,467
JardianceEmpagliflozin65$46,286
OzempicSemaglutide39$40,250
XareltoRivaroxaban40$30,525
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$14,081
FarxigaDapagliflozin Propanediol16$11,931
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$11,453
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog29$9,651
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,495
Novolog FlexpenInsulin Aspart17$3,876
Pantoprazole Sodium295$3,728
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$3,681
Gabapentin233$3,104
Potassium Chloride191$2,994
Rosuvastatin Calcium273$2,462

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$65,46770 claims
Boehringer IngelheimJardiance$279$46,28665 claims
Novo NordiskOzempic$931$40,25039 claims
Johnson & JohnsonXarelto$279$30,52540 claims
AstraZenecaFarxiga, Breztri Aerosphere$619$23,38427 claims
GSKTrelegy Ellipta$83$8,49511 claims
AbbVieSynthroid$329$2,35928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →